The weekly litigation news digest is live. Subscribe now

Patent Oppositions in large peptides industry

Explore the competitive field of large peptides where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in large peptides technology and learn how to protect your intellectual property.

Get Patent Opposition Report for large peptides

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the large peptides industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the large peptides industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Nov 20, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name
Method And Compositions For Cellular ImmunotherapyFRED HUTCHINSON CANCER CENTEROct 8, 2025BOULT WADE TENNANT
Antimicrobial Compounds From The Genus DelftiaMINISTRY OF HEALTHOct 1, 2025SCORPIO
Method For Generating T-Cells Compatible For Allogenic TransplantationCELLECTISOct 1, 2025CARPMAELS & RANSFORD SPECIALITIES
Method For Generating T-Cells Compatible For Allogenic TransplantationCELLECTISSep 30, 2025MARGARET DIXON
Method For Generating T-Cells Compatible For Allogenic TransplantationCELLECTISSep 29, 2025MURGITROYD
Engineered Gamma Delta T-CellsADICET THERAPEUTICSSep 25, 2025STRAWMAN
Non-Animal Based Protein Sources With Functional PropertiesCLARA FOODSSep 10, 2025VTT TECHNICAL RESEARCH CENTRE OF FINLAND
Use Of Tonicifying Agents To Enhance Recombinant Adeno-Associated Virus YieldULTRAGENYX PHARMACEUTICALAug 27, 2025STRAWMAN
Methods Of Making Chimeric Antigen Receptor -Expressing CellsNOVARTISAug 1, 2025STRAWMAN
Treatment Of Cancer By Manipulation Of Commensal MicrofloraTHE UNIVERSITY OF CHICAGOJul 16, 2025HGF

To stay ahead in the competitive large peptides industry, companies are constantly innovating. Here are the top patents facing oppositions in the large peptides industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleApplicantTotal Oppositions
Nov 1, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH11
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA10
Mar 1, 2023Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH9
Nov 29, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH9
May 10, 2017Protein Purification MethodCHUGAI SEIYAKU KABUSHIKI KAISHA7
Apr 19, 2017Oligopeptide-Free Cell Culture MediaBAXTER7
Jan 1, 2025Method For Generating T-Cells Compatible For Allogenic TransplantationCELLECTIS6
Nov 20, 2024Safe And Effective Method Of Treating Ulcerative Colitis With Anti-Il12/Il23 AntibodyJANSSEN BIOTECH6
Jan 29, 2020Process For Manipulating The Level Of Glycan Content Of A GlycoproteinAMGEN5
Oct 4, 2023Il-17 A/F Heterologous Polypeptides And Therapeutics Uses ThereofGENENTECH5